Core Viewpoint - The company has adjusted the repurchase price for the first category of restricted stock under the 2024 incentive plan due to two dividend distributions, which will not materially affect its financial status or operational results [2][3]. Group 1: Incentive Plan Details - On June 11, the company held its sixth board and supervisory meetings, approving the adjustment of the repurchase price for the 2024 restricted stock incentive plan [1]. - The initial grant date for the restricted stock was set for June 6, 2024, with a grant price of 6.63 yuan per share, distributing a total of 7,302,900 shares to 117 incentive targets [1]. - The first category of restricted stock consists of 3,844,966 shares granted to 30 individuals, while the second category includes 3,457,934 shares granted to 88 individuals [1]. Group 2: Dividend Distribution Impact - The company will distribute cash dividends of 1.540240 yuan per 10 shares on June 27, 2024, and 1.04 yuan per 10 shares on May 28, 2025, based on adjusted total share counts [2]. - The repurchase price for the first category of restricted stock is adjusted to approximately 6.372 yuan per share after accounting for the dividend distributions [2]. Group 3: Compliance and Approval - The adjustment complies with relevant regulations and has received approval from the independent directors, the board's remuneration and assessment committee, and the supervisory board [3]. - Legal opinions confirm that the adjustment process has followed necessary procedures, pending shareholder meeting approval for the termination and repurchase of the incentive plan [3].
迈克生物调整2024年限制性股票激励计划回购价格 ,调整后价格约6.372元/股